Last reviewed · How we verify
Vitreomacular traction syndrome
Approved treatments
- Jetrea · Thrombogenics, Inc
- Microplasmin · University of California, Los Angeles
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Vitreomacular traction syndrome patent landscape — cliff calendar, originator estates, attackable patents
- Vitreomacular traction syndrome treatment landscape brief
- Vitreomacular traction syndrome treatment updates RSS
Frequently asked questions about Vitreomacular traction syndrome
What drugs treat Vitreomacular traction syndrome?
Tracked treatments include Jetrea, Microplasmin.
What is the treatment for Vitreomacular traction syndrome?
Standard treatment for Vitreomacular traction syndrome includes Jetrea, Microplasmin. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Vitreomacular traction syndrome patent cliff · Vitreomacular traction syndrome CI report
- Treatment: Jetrea · Thrombogenics, Inc
- Treatment: Microplasmin · University of California, Los Angeles
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing